BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 16450916)

  • 1. Quality control in cervical cancer screening: Brazilian experience.
    Collaço LM; de Noronha L; Bleggi-Torres LF; Pinheiro DL
    Acta Cytol; 2005; 49(6):694-6. PubMed ID: 16450916
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
    Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
    Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scan-and-treat methodology using Azure A fast stain as a cost-effective cervical cancer screening alternative to visual inspection with acetic acid.
    Guillaud M; Benedet JL; Follen M; Crain BT; MacAulay C
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S256-9. PubMed ID: 17825881
    [No Abstract]   [Full Text] [Related]  

  • 4. Improving the sensitivity of cervical cytology: what are the issues?
    Myers ER
    Am J Manag Care; 2000 Jul; 6(7):838-40. PubMed ID: 11067380
    [No Abstract]   [Full Text] [Related]  

  • 5. Colposcopy, cervical screening, and HPV. Preface.
    Waxman AG
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):xv-xvi. PubMed ID: 19061813
    [No Abstract]   [Full Text] [Related]  

  • 6. Does the increased sensitivity of the new Papanicolaou (Pap) tests improve the cost-effectiveness of screening for cervical cancer?
    Reust CE
    J Fam Pract; 2001 Feb; 50(2):175. PubMed ID: 11219567
    [No Abstract]   [Full Text] [Related]  

  • 7. [A reply on cervix cancer screening: cervical cytological test doesn't fulfil the requirements of a good screening test].
    Bistoletti P
    Lakartidningen; 2000 Sep; 97(37):4042. PubMed ID: 11036367
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cervix cancer screening can be cost-effective. Combination of vaginal smears and the HPV test should be even more beneficial].
    Bistoletti P; Ellström A; Dillner J; Sennfält K; Sparén P; Strander B
    Lakartidningen; 2005 Jun 13-26; 102(24-25):1874-6, 1878-9. PubMed ID: 16044766
    [No Abstract]   [Full Text] [Related]  

  • 9. Public expectations, achievable cervical screening sensitivity, and the standard of practice.
    Austin RM
    Cancer; 2003 Feb; 99(1):1-3. PubMed ID: 12589638
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure.
    Manrique EJ; Amaral RG; Souza NL; Tavares SB; Albuquerque ZB; Zeferino LC
    Cytopathology; 2006 Jun; 17(3):116-20. PubMed ID: 16719853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based medicine--in real time. Comparing methods of cervical Ca screening.
    Genova NJ
    JAAPA; 2000 Jan; 13(1):55-6, 59-60, 63. PubMed ID: 11503224
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy of organized screening in comparison to spontaneous Pap samples in the prevention of invasive cervical cancer].
    Kallio M; Nieminen P; Anttila A; Hakama M
    Duodecim; 2001; 117(14):1442-6. PubMed ID: 12181953
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Liquid-based cytology for cervical screening.
    Blamey S; Jackson T; Robinson J
    Aust N Z J Obstet Gynaecol; 2006 Feb; 46(1):70-1; author reply 71-2. PubMed ID: 16441706
    [No Abstract]   [Full Text] [Related]  

  • 14. Can we change the way we screen?: the ThinPrep Imaging System.
    Dawson AE
    Cancer; 2004 Dec; 102(6):340-4. PubMed ID: 15540250
    [No Abstract]   [Full Text] [Related]  

  • 15. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.
    Levin CE; Sellors JW
    Cancer; 2002 Apr; 94(8):2312-4; author reply 2314-6. PubMed ID: 12001136
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cost-benefit of expanding cervical cancer screening].
    Deng J; Tan H; Yang T; Huang X; Zhou S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 May; 35(5):470-5. PubMed ID: 20543471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan.
    Koong SL; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S44-7. PubMed ID: 17227642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New ways of cervical cancer screening].
    Teikari M
    Duodecim; 2004; 120(13):1595-6; discussion 1596-7. PubMed ID: 15326967
    [No Abstract]   [Full Text] [Related]  

  • 19. [Costs and problems in cervix cancer screening are considerably underestimated].
    Bistoletti P
    Lakartidningen; 2000 Aug; 97(32-33):3506-8. PubMed ID: 11037597
    [No Abstract]   [Full Text] [Related]  

  • 20. Pap smear screening for cervical cancer in Singapore: issues to consider.
    Tay EH
    Singapore Med J; 2004 Jun; 45(6):244-6. PubMed ID: 15181515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.